Kim ST - Search Results

1

ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma.

Yen I, Shanahan F, Lee J, Hong YS, Shin SJ, Moore AR, Sudhamsu J, Chang MT, Bae I, Dela Cruz D, Hunsaker T, Klijn C, Liau NPD, Lin E, Martin SE, Modrusan Z, Piskol R, Segal E, Venkatanarayan A, Ye X, Yin J, Zhang L, Kim JS, Lim HS, Kim KP, Kim YJ, Han HS, Lee SJ, Kim ST, Jung M, Hong YH, Noh YS, Choi M, Han O, Nowicka M, Srinivasan S, Yan Y, Kim TW, Malek S. Yen I, et al. Among authors: kim yj, kim st, kim tw, kim kp, kim js. Nature. 2021 Jun;594(7863):418-423. doi: 10.1038/s41586-021-03515-1. Epub 2021 May 5. Nature. 2021. PMID: 33953400 Clinical Trial.

2

The different efficacy of gefitinib or erlotinib according to epidermal growth factor receptor exon 19 and exon 21 mutations in Korean non-small cell lung cancer patients.

Sun JM, Won YW, Kim ST, Kim JH, Choi YL, Lee J, Park YH, Ahn JS, Park K, Ahn MJ. Sun JM, et al. Among authors: kim st, kim jh. J Cancer Res Clin Oncol. 2011 Apr;137(4):687-94. doi: 10.1007/s00432-010-0928-2. Epub 2010 Jun 16. J Cancer Res Clin Oncol. 2011. PMID: 20552223

3

Prognostic model to predict outcomes in non-small cell lung cancer patients with erlotinib as salvage treatment.

Kim ST, Lee J, Sun JM, Park YH, Ahn JS, Park K, Ahn MJ. Kim ST, et al. Oncology. 2010;79(1-2):78-84. doi: 10.1159/000320190. Epub 2010 Nov 12. Oncology. 2010. PMID: 21071994

4

Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy.

Kim ST, Uhm JE, Lee J, Sun JM, Sohn I, Kim SW, Jung SH, Park YH, Ahn JS, Park K, Ahn MJ. Kim ST, et al. Among authors: kim sw. Lung Cancer. 2012 Jan;75(1):82-8. doi: 10.1016/j.lungcan.2011.05.022. Lung Cancer. 2012. PMID: 21684626 Clinical Trial.

5

Pazopanib, a novel multitargeted kinase inhibitor, shows potent in vitro antitumor activity in gastric cancer cell lines with FGFR2 amplification.

Kim ST, Jang HL, Lee SJ, Lee J, Choi YL, Kim KM, Cho J, Park SH, Park YS, Lim HY, Yashiro M, Kang WK, Park JO. Kim ST, et al. Among authors: kim km. Mol Cancer Ther. 2014 Nov;13(11):2527-36. doi: 10.1158/1535-7163.MCT-14-0255. Epub 2014 Sep 23. Mol Cancer Ther. 2014. PMID: 25249557

6

S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial.

Kim ST, Hong YS, Lim HY, Lee J, Kim TW, Kim KP, Kim SY, Baek JY, Kim JH, Lee KW, Chung IJ, Cho SH, Lee KH, Shin SJ, Kang HJ, Shin DB, Lee JW, Jo SJ, Park YS. Kim ST, et al. Among authors: kim tw, kim kp, kim sy, kim jh. BMC Cancer. 2014 Nov 26;14:883. doi: 10.1186/1471-2407-14-883. BMC Cancer. 2014. PMID: 25424120 Free PMC article. Clinical Trial.

7

Anti-tumor efficacy of fulvestrant in estrogen receptor positive gastric cancer.

Yi JH, Do IG, Jang J, Kim ST, Kim KM, Park SH, Park JO, Park YS, Lim HY, Kang WK, Lee J. Yi JH, et al. Among authors: kim st, kim km. Sci Rep. 2014 Dec 23;4:7592. doi: 10.1038/srep07592. Sci Rep. 2014. PMID: 25534230 Free PMC article. Clinical Trial.

8

Regorafenib as Salvage Treatment in Korean Patients with Refractory Metastatic Colorectal Cancer.

Kim ST, Kim TW, Kim KP, Kim TY, Han SW, Lee JY, Lim SH, Lee MY, Kim H, Park YS. Kim ST, et al. Among authors: kim h, kim tw, kim kp, kim ty. Cancer Res Treat. 2015 Oct;47(4):790-5. doi: 10.4143/crt.2014.126. Epub 2014 Dec 2. Cancer Res Treat. 2015. PMID: 25672574 Free PMC article. Clinical Trial.

9

The Role of Plasma Chromogranin A as Assessment of Treatment Response in Non-functioning Gastroenteropancreatic Neuroendocrine Tumors.

Kim M, Lee S, Lee J, Park SH, Park JO, Park YS, Kang WK, Kim ST. Kim M, et al. Among authors: kim st. Cancer Res Treat. 2016 Jan;48(1):153-61. doi: 10.4143/crt.2014.183. Epub 2015 Mar 7. Cancer Res Treat. 2016. PMID: 25779359 Free PMC article.

10

The impact of concomitant genomic alterations on treatment outcome for trastuzumab therapy in HER2-positive gastric cancer.

Lee JY, Hong M, Kim ST, Park SH, Kang WK, Kim KM, Lee J. Lee JY, et al. Among authors: kim st, kim km. Sci Rep. 2015 Mar 19;5:9289. doi: 10.1038/srep09289. Sci Rep. 2015. PMID: 25786580 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,717 results

Search Page